Gary Peters actually said...
This bipartisan, commonsense legislation would cut red tape for emerging biotechnology companies so they can focus their resources on the critical research and development that will provide innovative treatments and save lives.
Context
Gary Peters advocates for legislation to reduce regulatory burdens on biotech firms.
06/25/2018